Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 79.63B | 80.49B | 80.47B | 80.85B | 86.79B | 76.56B |
Gross Profit | 26.19B | 26.20B | 25.91B | 25.24B | 30.86B | 26.55B |
EBITDA | 7.54B | 8.86B | 10.64B | 10.42B | 13.92B | 11.62B |
Net Income | 3.73B | 4.15B | 5.45B | 5.86B | 7.79B | 6.16B |
Balance Sheet | ||||||
Total Assets | 159.62B | 157.76B | 164.82B | 155.94B | 155.46B | 150.06B |
Cash, Cash Equivalents and Short-Term Investments | 20.69B | 21.06B | 16.42B | 9.56B | 22.69B | 19.88B |
Total Debt | 5.81B | 5.59B | 5.79B | 2.52B | 3.08B | 3.05B |
Total Liabilities | 37.05B | 33.40B | 35.40B | 35.36B | 36.88B | 35.61B |
Stockholders Equity | 122.57B | 124.36B | 129.42B | 120.58B | 118.58B | 114.45B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 7.50B | 4.59B | -9.55B | 5.66B | 3.50B |
Operating Cash Flow | 0.00 | 11.54B | 7.91B | -7.59B | 8.43B | 6.60B |
Investing Cash Flow | 0.00 | -2.14B | -1.06B | 853.00M | -2.39B | -3.33B |
Financing Cash Flow | 0.00 | -4.71B | -533.00M | -6.35B | -2.90B | -2.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | €162.92B | 14.20 | 11.97% | 2.79% | 6.70% | 14.87% | |
75 Outperform | €166.48B | 7.45 | 23.27% | 1.49% | -1.36% | ― | |
75 Outperform | ¥112.78B | 15.61 | ― | 2.57% | 7.82% | 3.26% | |
70 Neutral | $624.13B | 14.86 | 5.27% | 3.82% | 0.86% | -15.62% | |
66 Neutral | $107.92B | 26.87 | 13.28% | 4.07% | -10.35% | -12.87% | |
62 Neutral | ¥91.49B | 23.72 | ― | 4.88% | -0.61% | -16.31% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |